Application of Artificial Intelligence or machine learning in risk sharing agreements for pharmacotherapy risk management

J Integr Bioinform. 2023 Dec 12. doi: 10.1515/jib-2023-0014. Online ahead of print.ABSTRACTApplications of Artificial Intelligence in medical informatics solutions risk sharing have social value. At a time of ever-increasing cost for the provision of medicines to citizens, there is a need to restrain the growth of health care costs. The search for computer technologies to stop or slow down the growth of costs acquires a new very important and significant meaning. We discussed the two information technologies in pharmacotherapy and the possibility of combining and sharing them, namely the combination of risk-sharing agreements and Machine Learning, which was made possible by the development of Artificial Intelligence (AI). Neural networks could be used to predict the outcome to reduce the risk factors for treatment. AI-based data processing automation technologies could be also used for risk-sharing agreements automation.PMID:38073025 | DOI:10.1515/jib-2023-0014
Source: Journal of integrative bioinformatics - Category: Bioinformatics Authors: Source Type: research